N-Acetylgalactosaminyltransferase 14 (GALNT14) is a mucin-type glycosylating enzyme polypeptide that promotes the migration of ovarian cancer by modifying mucin 13 (MUC13). GALNT14 can regulate the O-glycosylation and stability of MUC13, thereby mediating the malignant behavior of ovarian cancer cells[1].
Target:
Endogenous Metabolite
Application Notes:
MCE Product type: Enzyme
* VAT and and shipping costs not included. Errors and price changes excepted